• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55240376)   Find a Category (124)   Find a Journal (6141)   Find a Scholar (3962)   Find an Academic Assistant (17)
Find an Article PDF (4604935)   Today's Articles (3752)   Subscriber (49371)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
For: Capria S, Trisolini SM, Minotti C, Stefanizzi C, Cardarelli L, Cartoni C, Diverio D, De Propris MS, Mancini M, Micozzi A, Foà R, Meloni G. Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients. Mediterr J Hematol Infect Dis 2012;4:e2012072. [PMID: 23205260 DOI: 10.4084/MJHID.2012.072] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]  Open
Number Cited by Other Article(s)
1
Zhou Y, Yu F, Luo B, Luo H, Liu C. Cytrarabine (Ara-c) promotes cell apoptosis by inhibiting the phosphorylation of Protein Kinase B (AKT/PKB). Process Biochem 2019. [DOI: 10.1016/j.procbio.2019.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
2
Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children. J Pediatr Hematol Oncol 2018;40:163-168. [PMID: 29240026 DOI: 10.1097/mph.0000000000001010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA